Skip to main content
. 1999 Sep;67(9):4628–4636. doi: 10.1128/iai.67.9.4628-4636.1999

TABLE 2.

Prechallenge safety—clinical signs following vaccination with NOBL SC-54 or various vaccine candidate strains

Strain or group Timea Mortality (%)b Morbidity score (%)b Diarrhea score (%)b % of pigs culture positive (vaccine strains) ADG (kg) Mean temp (°C)c
Nonvaccinated, challenged Pre 0 0 1.0 39.4
Post 0 0 1.2 0 0.73 40.2*
Nonvaccinated, nonchallenged Pre 0 0 0 39.6
Post 0 0 0 0 0.69 40.3*
NOBL SC-54 Pre 0 0 0 39.8
Post 0 0 4.2 0 0.64 40.4*
χ3246 Pre 0 0 0 NT
Post 20.0 23.3 46.2 80.0 −0.03 NT
χ3781 Pre 0 0 8.3 39.4
Post 0 0 1.8 0 0.65 40.9**
χ3923 Pre 0 0 3.1 39.7
Post 0 0 1.2 0 0.65 40.6*
χ4186 Pre 0 0 1.0 39.5
Post 0 0 2.4 0 0.66 41.2**
χ4497 Pre 0 0 1.0 39.4
Post 0 0 0 0 0.70 40.0*
χ4522 Pre 0 4.1 5.2 39.8
Post 0 0 1.2 0 0.69 40.4*
χ4814 Pre 0 0 4.2 39.7
Post 0 0 3.0 0 0.70 40.2*
a

Pre, mean for the 4 days prior to vaccination; post, mean for the 1-week period postvaccination except for temperatures. 

b

Maximum possible severity is 100%. 

c

“Pre” values are the mean temperatures for the 4 days before vaccination. “Post” values are the mean maximum temperatures for the post vaccination period. NT, not tested. * and **, values in the same column with different superscripts are significantly different (P < 0.05).